Published in Cancer Weekly, June 22nd, 2004
"However, the optimal form of this therapy is still an enigma. This review discusses some of the current challenges in the hormonal management of prostate cancer, regarding complete androgen blockade, intermittent treatment, and the question of whether early hormonal deprivation is superior to delayed therapy," wrote C. Theodore and colleagues, Institute Gustave Roussy,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.